These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6450428)

  • 21. Kinetics of brain receptor binding inhibition by endogenous macromolecular substances [proceedings].
    Van Gompel P; Leysen JE
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B51-B53. PubMed ID: 6155859
    [No Abstract]   [Full Text] [Related]  

  • 22. [Physiological function of sigma receptors: central pharmacological effects of sigma ligands].
    Nabeshima T; Okuyama S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Apr; 14(2):51-76. PubMed ID: 8042346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of single and repeated phencyclidine administration on [3H]flunitrazepam binding in rat brain.
    Abe S; Suzuki T; Endo K; Hori T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):133-40. PubMed ID: 15610955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of phencyclidine receptor sensitivity.
    Quirion R; Pert CB
    NIDA Res Monogr; 1983 Apr; 43():217-23. PubMed ID: 6308454
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody.
    Laurenzana EM; Gunnell MG; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1092-8. PubMed ID: 12829731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction.
    Chang MC; Berkery D; Schuel R; Laychock SG; Zimmerman AM; Zimmerman S; Schuel H
    Mol Reprod Dev; 1993 Dec; 36(4):507-16. PubMed ID: 8305215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats.
    Proksch JW; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):831-7. PubMed ID: 10688594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H; Mausset AL; Kamenka JM; Privat A; Vignon J
    J Neurosci Res; 2002 May; 68(3):305-14. PubMed ID: 12111860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of specific binding of [3H]phorbol 12,13-dibutyrate and [3H]phorbol 12-myristate 13-acetate to mouse brain.
    Dunphy WG; Delclos KB; Blumberg PM
    Cancer Res; 1980 Oct; 40(10):3635-41. PubMed ID: 7438048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of receptor-bearing membranes from rat brain microsomes after digitonin treatment [proceedings].
    Laduron P; Janssen PF
    Arch Int Physiol Biochim; 1979 May; 87(2):419-20. PubMed ID: 92963
    [No Abstract]   [Full Text] [Related]  

  • 32. Phencyclidine.
    Snyder SH
    Nature; 1980 Jun; 285(5764):355-6. PubMed ID: 7189825
    [No Abstract]   [Full Text] [Related]  

  • 33. "Specific binding" of 3H-phencyclidine: artifacts of the rapid filtration method.
    Maayani S; Weinstein H
    Life Sci; 1980 Jun; 26(23):2011-22. PubMed ID: 7401913
    [No Abstract]   [Full Text] [Related]  

  • 34. Disposition of [3H] phencyclidine in the rat after single and multiple doses.
    Misra AL; Pontani RB; Bartolomeo JG
    Life Sci; 1980 Dec 22-29; 27(25-26):2501-8. PubMed ID: 7219023
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitative receptor autoradiography.
    Nature; 1987 Apr 16-22; 326(6114):648-9. PubMed ID: 3561509
    [No Abstract]   [Full Text] [Related]  

  • 36. Smoking of phencyclidine: disposition in man and stability to pyrolytic conditions.
    Cook CE; Brine DR; Quin GD; Wall ME; Perez-Reyes M; Di Guiseppi SR
    Life Sci; 1981 Nov; 29(19):1967-72. PubMed ID: 7311728
    [No Abstract]   [Full Text] [Related]  

  • 37. New and experimental therapeutic roles for naloxone and related opioid antagonists.
    McNicholas LF; Martin WR
    Drugs; 1984 Jan; 27(1):81-93. PubMed ID: 6319107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of disruptive effects of dextromethorphan by naloxone on fixed-interval performance in rats.
    Taşkin T
    Psychopharmacology (Berl); 1986; 90(3):408-11. PubMed ID: 3097731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (3H)-Phencyclidine binding to specific brain receptor sites [proceedings].
    Zukin SR; Zukin RS
    Psychopharmacol Bull; 1980 Oct; 16(4):59-62. PubMed ID: 6450428
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of phencyclidine and sigma receptor-binding sites in brain.
    Gundlach AL; Largent BL; Snyder SH
    NIDA Res Monogr; 1986; 64():1-13. PubMed ID: 3012343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.